designed to provide fast results for predictive medical intervention for patients experiencing seizure activity
for patients who experience the onset of seizures, infantile spasms, encephalopathy, or recurrent febrile seizures before 2 years of age
for patients who experience the onset of seizures, infantile spasms, encephalopathy, or recurrent febrile seizures after 2 years of age
for patients who experience the onset of seizures during adolescence (>12 years old) or adulthood
designed to include a comprehensive set of genes that have seizure activity as a clinical presentation
Panel Coverage: 96% at 20x Guaranteed
Deletion / Duplication: ≥ 2 exons
Sequencing Methods: NGS
Orthogonal Methods: Sanger, qPCR, MLPA
Turnaround Time: 3-5 weeks